ADAR1 Capital Management, LLC, 10% owner at InMed Pharmaceuticals, bought INM on Jul 15, 2026
Data as of Oct 16
▲ BUY$1.6K1,000 shares at $1.55ADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.
- Traded
- Jul 15, 2026
- Disclosed
- Jul 17, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
INM since disclosure
−13.2%
Similar stocks (XLV) since disclosure
+9.7%
XLV — its sector index fund
Change in closing price from Jul 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$1.6Kdisclosed Jul 17 · filed 2 days after the trade